Biotech

All Articles

Daiichi pays Merck $170M to form lung cancer cells T-cell engager deal

.Merck &amp Co. has swiftly recouped a few of the costs of its Weapon Rehabs acquistion, pulling in ...

BioMarin standstills preclinical genetics therapy for heart disease

.After BioMarin administered a spring well-maintained of its own pipe in April, the firm has actuall...

Eisai vegetations molecular adhesive SEED with $1.5 B biobucks work

.Big Pharmas stay stuck to the concept of molecular glue degraders. The latest company to see an opp...

Life scientific research credit rating organization introduces with $600M

.A brand new international life scientific research credit score company, called Symbiotic Funds, ha...

BMS ditches TIGIT, leaving $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing one more huge bet coming from the Caforio age, ending a package for A...

Nuvation halts BET inhibitor after thinking about stage 1 record

.After having a look at phase 1 information, Nuvation Biography has actually chosen to stop focus on...

' Professional instinct' led FDA specialists to back Zevra's uncommon disease med

.Zevra Rehabs' uncommon condition medicine appears to become on the road to authorization this fall ...

Pfizer takes $230M hit after axing fell short DMD gene therapy

.Pfizer's period 3 Duchenne muscle dystrophy (DMD) gene treatment breakdown has blown a $230 million...

AC Immune sees 'landmark' prospective in Alzheimer's medicine data

.After more than twenty years of focus on neurodegenerative diseases, Swiss biotech air conditioning...

GSK goes down ph. 2 HPV vaccination over absence of best-in-class potential

.GSK has actually broken up a stage 2 individual papillomavirus (HPV) vaccine coming from its own pi...